Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

February 21, 2024

Study Completion Date

February 28, 2024

Conditions

Renal Insufficiency

Interventions

DRUG

ET-26HCl

The dose is 0.8 mg/kg, single dose, Infusion time was 60s ± 5s.

Trial Locations (1)

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital of Shandong Province), Jinan